Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -18.77% vs 46.23% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 29.81% vs 28.25% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024
Compare Profit and Loss Results of Anuh Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
661.00
304.00
357.00
117.43%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
661.00
304.00
357.00
117.43%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
10.00
-12.00
-120.00%
Raw Materials Consumed
501.00
179.00
322.00
179.89%
Power & Fuel Cost
12.00
4.00
8.00
200.00%
Employee Cost
23.00
21.00
2.00
9.52%
Operating Expenses
28.00
13.00
15.00
115.38%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
25.00
-15.00
-60.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
19.00
7.00
12.00
171.43%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
599.00
270.00
329.00
121.85%
Operating Profit (PBDIT) excl Other Income
61.00
33.00
28.00
84.85%
Other Income
9.00
14.00
-5.00
-35.71%
Operating Profit (PBDIT)
70.00
48.00
22.00
45.83%
Interest
1.00
4.00
-3.00
-75.00%
Profit before Depriciation and Tax
69.00
43.00
26.00
60.47%
Depreciation
8.00
7.00
1.00
14.29%
Profit Before Taxation & Exceptional Items
61.00
36.00
25.00
69.44%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
61.00
36.00
25.00
69.44%
Provision for Tax
13.00
9.00
4.00
44.44%
Profit After Tax
47.00
26.00
21.00
80.77%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
156.00
205.00
-49.00
-23.90%
Profit Available for appropriations
203.00
231.00
-28.00
-12.12%
Appropriations
203.00
231.00
-28.00
-12.12%
Equity Dividend (%)
30%
10%
20.00
Earnings Per Share
9.45
40.36
-30.91
-76.59%
Profit And Loss - Net Sales
Net Sales 661.51 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 61.53 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.77% vs 46.23% in Mar 2024
Profit And Loss - Interest
Interest 1.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.81% vs 28.25% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 47.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024






